Overview

Infectious diseases claim over 17 million lives annually, posing a severe threat to global health. Rapid and accurate pathogen detection is critical for effective treatment and prevention. Conventional tools like real-time PCR and antibody-based assays detect only a few pathogens at a time, often with low sensitivity and risk of false negatives. While PCR can identify pathogens during outbreaks, it lacks sequence-level data, making it impossible to trace transmission pathways or cluster cases accurately. High-resolution whole-genome sequencing of pathogens from vectors and reservoirs unlocks insights into epidemiology and evolution. Yet, traditional NGS approaches struggle with low pathogen-to-host DNA ratios. Our advanced solutions overcome these challenges, delivering high-quality pathogen sequence data for precision diagnostics and research.

Genes2Me Pan Pathogen Assay leverages targeted next-generation sequencing (tNGS) with advanced hybridization capture technology to enrich pathogen-specific genes from complex samples. Powered by a clinical-grade reference database, patented innovations, and intelligent bioinformatics algorithms, this solution detects pathogens (viruses, bacteria, fungi, parasites and other pathogenic microorganisms), drug-resistance genes, and virulence markers with unmatched accuracy. Designed to support precise diagnosis and targeted treatment, the panel enables clinicians to identify infections, assess resistance profiles, and guide effective therapeutic decisions all in one streamlined workflow.